Skip to main content

MARSHALL WACE, LLP

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in PLRX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,254,925
-$62,830 QoQ
Shares Held
995,973
-7.8% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
10 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in PLRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. PLRX ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PLRX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,254,925 995,973
2025-12-31 $1,317,755 1,080,128
2025-09-30 $443,202 299,461
2025-03-31 $281,518 208,532
2024-12-31 $709,599 53,880
2024-03-31 $1,950,931 130,935
2023-09-30 $1,281,789 73,921
2023-03-31 $993,616 37,354
2022-12-31 $1,272,300 65,820
2022-06-30 $371,775 46,414